Skip to content

Quantitative Assessment of Walking (Squawk) With the Canary canturioTM te (CTE) Tibial Extension

A Multicenter, Single- Arm Study of Quantitative Assessment of Walking (Squawk) With the Canary canturioTM te (CTE) Tibial Extension

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05693818
Enrollment
88
Registered
2023-01-23
Start date
2023-01-31
Completion date
2024-05-15
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis Knee

Keywords

total knee arthroplasty, PersonaIQ

Brief summary

The objective of this prospective study is to demonstrate accuracy of a limp detection model using a healthcare provider assessment as the non-reference standard.

Detailed description

The primary endpoint of the study is limp severity at the 4-6 week office visit. At 4-6 weeks (+/- 3 days) post-surgery, the healthcare team will assess the patient's limp severity by visual observation on a 3-point Likert scale (0=No limp, 1=Mild/Moderate or 2=Severe).

Interventions

OTHERClinical Limping Evalution

Patients will be asked to perform a Clinical Limping Evaluation in the clinic during their post-operative follow-up visit. This will be performed in a controlled environment within the physician's clinic. Each patient will be asked to walk at their normal walking speed down a hallway for at least 7 consecutive steps and back toward the physician. Walking down the hallway and back is one walking trial. Each patient will be asked to perform 2 walking trials. The health care provider will assess the patient's limp using a 3-point Likert scale (0=No limp, 1=mild/moderate limp, 2=severe limp). If required, patients may use an assistive device and the type of device should be documented. If a patient requires assistance, only the minimum amount of assistance required for a patient to complete the task should be provided.

Sponsors

Canary Medical
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Patient must be 18 years of age or older * Independent of study participation, patient is indicated for a commercially available PIQ TKA implant in accordance with product labeling * Patient must be willing and able to complete the protocol required follow-up * Patient has participated in the study-related informed consent process * Patient is willing and able to provide written Informed Consent by signing and dating the IRB approved informed consent

Exclusion criteria

* • Simultaneous bilateral TKA * Staged bilateral TKA less than 6 months from indexed procedure * Patient is a current alcohol or drug abuser * Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.) * Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program * Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions * Patient with Neuropathic Arthropathy * Patient with any loss of musculature or neuromuscular disease that compromises the affected limb * Patients with known symptomatic foot, hip or spinal injuries and/or conditions that could affect gait

Design outcomes

Primary

MeasureTime frameDescription
Limp Severity4-6 wks+3 days weeks post TKAThe primary endpoint of the study is limp severity at the 4-6 week office visit. At 4-6 weeks (+/- 3 days) post-surgery, the healthcare team will assess the patient's limp severity by visual observation on a 3-point Likert scale (0=No limp, 1=Mild/Moderate or 2=Severe).

Secondary

MeasureTime frameDescription
Positive Percent Agreement (PPA) of the CMLM with the healthcare team's assessment4-6 wks+3 days weeks post TKAPositive Percent Agreement (PPA)
Negative Percent Agreement (NPA) of the CMLM with the healthcare team's assessment4-6 wks+3 days weeks post TKANegative Percent Agreement (NPA)
Knee Range of Motion4-6 wks+3 days weeks post TKAROM will be measured by a goniometer
Test-retest reliability of the Canary Medical Limping Model (CMLM) score4-6 wks+3 days weeks post TKATest-retest reliability of the CMLM score from day-to-day and week-to-week. (Specific days and weeks will be provided in the Statistical Analysis Plan.)
KOOS Jr4-6 wks+3 days weeks post TKAPatient Reported outcome
Limping Self Evaluation4-6 wks+3 days weeks post TKAStudy participants will be asked the following question, During the past week, have you been limping when walking, because of your knee? The following answers will be allowed: * Rarely / never * Sometimes or just at first, after sitting for a long time * Often, not just at first * Most of the time * All of the time
Numeric Pain Rating Scale4-6 wks+3 days weeks post TKASubjective Pain Measurement

Countries

United States

Contacts

Primary ContactDerek E. Coulter
dcoulter@canarymedical.com18066816979
Backup ContactNora York
nyork@canarymedical.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026